Human eosinophils exert TNF-α and granzyme a-mediated tumoricidal activity toward colon carcinoma cells

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7443-7451

  Legrand, Fanny ^a,b,c   Driss, Virginie ^a   Delbeke, Marie ^a,b   Loiseau, Sylvie ^a,b   Hermann, Emmanuel ^a,d   Dombrowicz, David ^a,e   Capron, Monique ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c UNIV LILLE   (France)

^d INSERM U1019   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; EOSINOPHIL CATIONIC PROTEIN; GRANZYME A; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; NAFAMSTAT MESILATE; NEUROTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ADHESION; COCULTURE; COLON CARCINOMA; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR CELL DESTRUCTION;

ANTIBODIES; ANTIGENS, CD11A; ANTIGENS, CD18; APOPTOSIS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; EOSINOPHILIA; EOSINOPHILS; GRANZYMES; GUANIDINES; HUMANS; IMMUNITY, INNATE; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650632745     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000446     Document Type: Article

References (52)

1. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24:147-174.
2. Jacobsen, E. A., A. G. Taranova, N. A. Lee, and J. J. Lee. 2007. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J. Allergy Clin. Immunol. 119:1313-1320.
3. Munitz, A., and F. Levi-Schaffer. 2004. Eosinophils: 'new' roles for 'old' cells. Allergy 59:268-275.
4. Lotfi, R., J. J. Lee, and M. T. Lotze. 2007. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J. Immunother. 30:16-28.
5. Lowe, D., J. Jorizzo, and M. S. Hutt. 1981. Tumour-associated eosinophilia: a review. J. Clin. Pathol. 34:1343-1348.
6. Carrozzi, L., and G. Viegi. 2005. Allergy and cancer: a biological and epidemiological rebus. Allergy 60:1095-1097.
7. Dorta, R. G., G. Landman, L. P. Kowalski, J. R. Lauris, M. R. Latorre, and D. T. Oliveira. 2002. Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 41:152-157.
8. Fujii, M., T. Yamashita, R. Ishiguro, M. Tashiro, and K. Kameyama. 2002. Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29:175-181.
9. Goldsmith, M. M., D. A. Belchis, D. H. Cresson, W. D. Merritt, III, and F. B. Askin. 1992. The importance of the eosinophil in head and neck cancer. Otolaryngol. Head Neck Surg. 106:27-33.
10. Nielsen, H. J., U. Hansen, I. J. Christensen, C. M. Reimert, N. Brünner, and F. Moesgaard. 1999. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J. Pathol. 189:487-495.
11. Fernández-Aceñero, M. J., M. Galindo-Gallego, J. Sanz, and A. Aljama. 2000. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 88:1544-1548.
12. Cormier, S. A., A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al. 2006. Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukoc. Biol. 79:1131-1139.
13. Mattes, J., M. Hulett, W. Xie, S. Hogan, M. E. Rothenberg, P. Foster, and C. Parish. 2003. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J. Exp. Med. 197:387-393.
14. Simson, L., J. I. Ellyard, L. A. Dent, K. I. Matthaei, M. E. Rothenberg, P. S. Foster, M. J. Smyth, and C. R. Parish. 2007. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immunesurveillance. J. Immunol. 178:4222-4229.
15. Wagner, L., K. M. Leiferman, and G. J. Gleich. 2006. Eosinophils. In: Encyclopedia of Life Sciences. John Wiley & Sons, New York. Available at: http://onlinelibrary.wiley.com/doi/10.1002/9780470015902.a0001126/full.
16. Spencer, L. A., C. T. Szela, S. A. Perez, C. L. Kirchhoffer, J. S. Neves, A. L. Radke, and P. F. Weller. 2009. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 85:117-123.
17. Woerly, G., N. Roger, S. Loiseau, D. Dombrowicz, A. Capron, and M. Capron. 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J. Exp. Med. 190:487-495.
18. Legrand, F., V. Driss, G. Woerly, S. Loiseau, E. Hermann, J. J. Fournié, L. Héliot, V. Mattot, F. Soncin, M. L. Gougeon, et al. 2009. A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils. PLoS ONE 4: e5926.
19. Caruso, R. A., F. Fedele, V. Zuccalá, M. G. Fracassi, and A. Venuti. 2007. Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations. Anticancer Res. 27 (1 A): 391-394.
20. Caruso, R. A., A. Ieni, F. Fedele, V. Zuccalá, M. Riccardo, E. Parisi, and A. Parisi. 2005. Degranulation patterns of eosinophils in advanced gastric carcinoma: an electron microscopic study. Ultrastruct. Pathol. 29:29-36.
21. Munitz, A., I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H. U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer. 2005. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174:110-118.
22. Espinosa, E., C. Belmant, F. Pont, B. Luciani, R. Poupot, F. Romagné, H. Brailly, M. Bonneville, and J. J. Fournié. 2001. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells. J. Biol. Chem. 276:18337-18344.
23. Gertner, J., A. Wiedemann, M. Poupot, and J. J. Fournié. 2007. Human gammadelta Tlymphocytes strip and kill tumor cells simultaneously. Immunol. Lett. 110:42-53.
24. Li, J., M. J. Herold, B. Kimmel, I. Müller, B. Rincon-Orozco, V. Kunzmann, and T. Herrmann. 2009. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells. J. Immunol. 182:8118-8124.
25. Sheehy, M. E., A. B. McDermott, S. N. Furlan, P. Klenerman, and D. F. Nixon. 2001. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 249:99-110.
26. Bielawska-Pohl, A., C. Crola, A. Caignard, C. Gaudin, D. Dus, C. Kieda, and S. Chouaib. 2005. Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms. J. Immunol. 174:5573-5582.
27. Shibuya, A., L. L. Lanier, and J. H. Phillips. 1998. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J. Immunol. 161:1671-1676. (Pubitemid 28387583)
28. Bade, B., H. E. Boettcher, J. Lohrmann, C. Hink-Schauer, K. Bratke, D. E. Jenne, J. C. Virchow, Jr., and W. Luttmann. 2005. Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes. Int. Immunol. 17:1419-1428.
29. Driss, V., F. Legrand, E. Hermann, S. Loiseau, Y. Guerardel, L. Kremer, E. Adam, G. Woerly, D. Dombrowicz, and M. Capron. 2009. TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113:3235-3244.
30. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26:389-420.
31. Poe, M., J. K. Wu, J. T. Blake, H. J. Zweerink, and N. H. Sigal. 1991. The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175. Arch. Biochem. Biophys. 284:215-218.
32. Nutten, S., J. P. Papin, G. Woerly, D. W. Dunne, J. MacGregor, F. Trottein, and M. Capron. 1999. Selectin and Lewis (x) are required as co-receptors in antibodydependent cell-mediated cytotoxicity of human eosinophils to Schistosoma mansoni schistosomula. Eur. J. Immunol. 29:799-808.
33. Kato, Y., Y. Tanaka, M. Hayashi, K. Okawa, and N. Minato. 2006. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens. J. Immunol. 177:877-884.
34. Corvaisier, M., A. Moreau-Aubry, E. Diez, J. Bennouna, J. F. Mosnier, E. Scotet, M. Bonneville, and F. Jotereau. 2005. V gamma 9V delta 2 T cell response to colon carcinoma cells. J. Immunol. 175:5481-5488.
35. Lantero, S., G. Alessandri, D. Spallarossa, L. Scarso, and G. A. Rossi. 1998. LFA-1 expression by blood eosinophils is increased in atopic asthmatic children and is involved in eosinophil locomotion. Eur. Respir. J. 12:1094-1098.
36. Chang, K. C., C. W. Lo, T. C. Fan, M. D. Chang, C. W. Shu, C. H. Chang, C. T. Chung, S. L. Fang, C. C. Chao, J. J. Tsai, and Y. K. Lai. 2010. TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells. BMC Cell Biol. 11:6.
37. Herbeuval, J. P., C. Lambert, O. Sabido, M. Cottier, P. Fournel, M. Dy, and C. Genin. 2003. Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis. J. Natl. Cancer Inst. 95:611-621.
38. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2:735-747.
39. Hochegger, K., P. Eller, and A. R. Rosenkranz. 2004. Granzyme A: an additional weapon of human polymorphonuclear neutrophils (PMNs) in innate immunity? Blood 103:1176.
40. Hochegger, K., P. Eller, J. M. Huber, D. Bernhard, G. Mayer, G. J. Zlabinger, and A. R. Rosenkranz. 2007. Expression of granzyme A in human polymorphonuclear neutrophils. Immunology 121:166-173.
41. Palm-Apergi, C., A. Lorents, K. Padari, M. Pooga, and M. Hallbrink. 2009. The membrane repair response masks membrane disturbances caused by cellpenetrating peptide uptake. FASEB J. 23:214-223.
42. Yoshikawa, Y., H. Hirayasu, S. Tsuzuki, and T. Fushiki. 2008. Granzyme A causes detachment of alveolar epithelial A549 cells accompanied by promotion of interleukin-8 release. Biosci. Biotechnol. Biochem. 72:2481-2484.
43. Hirayasu, H., Y. Yoshikawa, S. Tsuzuki, and T. Fushiki. 2008. A lymphocyte serine protease granzyme A causes detachment of a small-intestinal epithelial cell line (IEC-6). Biosci. Biotechnol. Biochem. 72:2294-2302.
44. Hirayasu, H., Y. Yoshikawa, S. Tsuzuki, and T. Fushiki. 2007. A role of a lymphocyte tryptase, granzyme A, in experimental ulcerative colitis. Biosci. Biotechnol. Biochem. 71:234-237.
45. Chattopadhyay, P. K., M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85:88-97.
46. Newton, D. L., and S. M. Rybak. 1998. Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth. J. Natl. Cancer Inst. 90:1787-1791.
47. Maeda, T., M. Kitazoe, H. Tada, R. de Llorens, D. S. Salomon, M. Ueda, H. Yamada, and M. Seno. 2002. Growth inhibition of mammalian cells by eosinophil cationic protein. Eur. J. Biochem. 269:307-316.
48. Chang, C., D. L. Newton, S. M. Rybak, and A. Wlodawer. 2002. Crystallographic and functional studies of a modified form of eosinophil-derived neurotoxin (EDN) with novel biological activities. J. Mol. Biol. 317:119-130.
49. Carreras, E., E. Boix, S. Navarro, H. F. Rosenberg, C. M. Cuchillo, and M. V. Nogués. 2005. Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol. Cell. Biochem. 272:1-7.
50. Young, J. D., C. G. Peterson, P. Venge, and Z. A. Cohn. 1986. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321:613-616.
51. Torrent, M., E. Cuyás, E. Carreras, S. Navarro, O. López, A. de la Maza, M. V. Nogués, Y. K. Reshetnyak, and E. Boix. 2007. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry 46:720-733.
52. Navarro, S., J. Aleu, M. Jiménez, E. Boix, C. M. Cuchillo, and M. V. Nogués. 2008. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell. Mol. Life Sci. 65:324-337.